Bio Fund Management

· Bio Fund Management
· Focused Biotechnology Sector

– Microbiome

– Immune Checkpoint

– CAR-T

– ADC (Antibody Drug Conjugate)

– Bi-specific Antibody, etc.

· Target Company

– The overseas Biotechnology company which aims to go public on KRX and NASDAQ

– The Company`s Technology is undergoing pre-clinical or first clinical stage

· Size of Investment and Duration

– Investment Size: USD 3M ~ 30M

– Investment Duration: 5 years

· Investment Procedure


Visit Overseas Bio Company


Document and IR


LP Road-show


Due Diligence


Term sheet and contract


Investment

“ THE LEADING SOUTHEAST ASIAN CROSS-BORDER COMPANY OF KOREA ”

footer